Injection-related anthrax constitutes a systemic presentation of anthrax, placing it in a category that requires prompt, structured clinical management. The treatment approach for this form differs from localised cutaneous disease and follows a defined protocol.
This protocol applies when anthrax is acquired or presents through the injection route. Injection-related anthrax meets the definition of systemic anthrax, which guides the selection and intensity of the therapeutic approach.
Management requires empiric combination antibiotic therapy — two agents selected according to a structured algorithm — alongside surgical debridement of the injection site. The complete regimen, including agent selection criteria and treatment duration, follows evidence-based guidance.
Systemic anthrax is defined as any of the following: 4) Injection-related anthrax.
In the presence of any of these scenarios, empiric combination therapy with two antibiotics is recommended.
Two antibiotics, surgical debridement and antitoxin.
View source ↗